Due to a late surge in the number of abstract submissions, the final deadline has now been extended to July 1. Click here for more information.
Registration is open to attend the Joint Global Neurofibromoatosis Conference, a global event attracting more than 800 participants worldwide across a wide range of scientific disciplines, from research and clinical backgrounds, all focused on improving outcomes for patients with neurofibromatosis type 1 (NF1), neurofibromatosis type 2 (NF2) and schwannomatosis. The conference takes place November 2-6, 2018 in Paris, France. For more information and registration, click here.
